RFA- Studies Addressing Clinically Relevant Questions About Ketones And The Use Of Continuous Ketone Monitoring In Type 1 Diabetes Grant
Funding Amount
Up to US $1,500,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Required status
- 501(c)(3) tax-exempt status
Overview
Breakthrough T1D is inviting studies that address clinically relevant questions about ketones and the use of continuous ketone monitoring (CKM) in type 1 diabetes. As CKMs provide continuous data, they can enhance our understanding of ketone dynamics and their implications for diabetes management and DKA prevention. This initiative aims to foster innovative research that can lead to improved treatments and outcomes for individuals living with type 1 diabetes.
Breakthrough T1D
Founded in 1970 by families whose loved ones had been diagnosed with type 1 diabetes (T1D), Breakthrough T1D is a tax-exempt nonprofit 501(c)3 organization.
We lead the way to more effective solutions by connecting the brightest minds to advance treatments, influence policy, and improve access to care. By driving innovation forward, Breakthrough T1D will make type 1 diabetes a condition of the past.
Studies addressing clinically relevant questions about ketones and the use of continuous ketone monitoring in type 1 diabetes
Purpose
Circulating ketones are clinically relevant metabolites in type 1 diabetes (T1D). To date, most of our knowledge about ketones in T1D has come from point-of-care blood and urine ketone measurements, which provide only snapshots in time and lack the temporal resolution needed to fully understand ketone dynamics. Today, emerging continuous ketone monitors (CKMs) allow us to answer questions we never could before about the pathophysiology of T1D and its complications, DKA prevention, and other topics. Breakthrough T1D invites letters of intent for studies addressing clinically relevant questions about ketones and the use of CKM in T1D.
What Breakthrough T1D actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 100
- Total given
- $79.32M
- Median grant
- $378K
- Range
- $25K–$7.28M
- By dollars: Massachusetts 21%, California 13%, Florida 7%. Top recipient cities: Boston, MA; New York, NY; Seattle, WA.
- 0% of grants with a stated purpose were for general or operating support.
- 16% of recipients were new grantees, not repeat recipients.
Example grants
University of Massachusetts Medical School · Worcester, MA
T1d research
$7.28M
The Regents of the University of California San Francisco · San Francisco, CA
T1d research
$5.4M
The University of Chicago · Chicago, IL
T1d research
$4.12M
Regents of the University of Colorado · Denver, CO
T1d research
$3.58M
University of Florida · Gainesville, FL
T1d research
$3.13M
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
RFA- Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation Grant
Breakthrough T1D
Amount
Up to US $900,000
Deadline
Deadline not published
Breakthrough T1D- Innovative Awards Grant
Breakthrough T1D
Amount
Up to US $200,000
Deadline
Deadline not published
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
Breakthrough T1D Project Concepts Grant
Breakthrough T1D
Amount
Varies
Deadline
Deadline not published
Clinical Trials Advancing Metabolic Therapies for T1D RFA
Breakthrough T1D
Amount
Varies
Deadline
Deadline not published
In vitro Disease Modeling: Type I Diabetes-on-a-Chip Platforms for Translational Research Grant
Breakthrough T1D
Amount
Up to US $300,000
Deadline
Deadline not published
Ready to apply for RFA- Studies Addressing Clinically Relevant Questions About Ketones And The Use Of Continuous Ketone Monitoring In Type 1 Diabetes Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found RFA- Studies Addressing Clinically Relevant Questions About Ketones And The Use Of Continuous Ketone Monitoring In Type 1 Diabetes Grant. Now let's win it.